These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2134622)

  • 21. Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic patients.
    Schnaidt M; Northoff H; Wernet D
    Transfus Med; 1996 Jun; 6(2):111-4. PubMed ID: 8809957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theoretic and practical aspects of platelet crossmatching.
    von dem Borne AE; Ouwehand WH; Kuijpers RW
    Transfus Med Rev; 1990 Oct; 4(4):265-78. PubMed ID: 2134633
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe anaphylactic transfusion reaction associated with HLA-incompatible platelets.
    Take H; Tamura J; Sawamura M; Murakami H; Naruse T; Tsuchiya J; Miyawaki S; Hirabayashi H
    Br J Haematol; 1993 Apr; 83(4):673-4. PubMed ID: 8518185
    [No Abstract]   [Full Text] [Related]  

  • 25. [Platelet antigens and antibodies against them].
    Zotikov EA
    Biull Eksp Biol Med; 2000 Mar; 129(3):244-7. PubMed ID: 10776555
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA antigen and antibody association in platelet-alloimmunized patients.
    Chow MP; Lin JS; Lin CK; Kuo BI; Yung CH; Lyou JY; Hu HY; Tzeng JL; Lee TD
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):329-32. PubMed ID: 8334558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunological complications of platelet transfusion].
    Godeau B; Bierling P
    Ann Med Interne (Paris); 1992; 143(2):123-7. PubMed ID: 1530220
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunological aspects of platelet transfusions.
    Murphy MF; Waters AH
    Br J Haematol; 1985 Jul; 60(3):409-14. PubMed ID: 4015986
    [No Abstract]   [Full Text] [Related]  

  • 29. Report on the Third Canadian Workshop on Platelet Serology.
    Bonacossa IA
    Transfus Med Rev; 1990 Apr; 4(2):87-90. PubMed ID: 2134626
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet antibodies: their detection and significance.
    Harmon JA; Miller WV
    Am J Med Technol; 1981 Oct; 47(10):797-802. PubMed ID: 7036742
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion medicine. Introduction to Vol. 25, No. 3 of immunohematology.
    AuBuchon JP
    Immunohematology; 2009; 25(3):89. PubMed ID: 20406012
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and circumvention of refractoriness to platelet transfusions: interface between preparative and therapeutic apheresis.
    Beris P; Dornier C
    Curr Stud Hematol Blood Transfus; 1990; (57):267-76. PubMed ID: 2272206
    [No Abstract]   [Full Text] [Related]  

  • 35. Alloimmunization to the PlA1 platelet antigen: results of a prospective study.
    Blanchette VS; Chen L; de Friedberg ZS; Hogan VA; Trudel E; Décary F
    Br J Haematol; 1990 Feb; 74(2):209-15. PubMed ID: 2317456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood transfusion and blood-derived products transfusion. Immunologic principles and indications].
    Lamy B; Morel P; Hervé P
    Rev Prat; 1998 Mar; 48(5):549-53. PubMed ID: 9781121
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelets compatible for both ABO and HLA.
    McVey M; Cserti-Gazdewich CM
    Transfus Med; 2010 Oct; 20(5):346-53. PubMed ID: 20492602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiplatelet antibody].
    Shibata Y; Yamanaka M
    Rinsho Byori; 1985 Jul; 33(7):734-41. PubMed ID: 3934431
    [No Abstract]   [Full Text] [Related]  

  • 39. Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.
    Saris A; Peyron I; van der Meer PF; Stuge TB; Zwaginga JJ; van Ham SM; Ten Brinke A
    Front Immunol; 2018; 9():1251. PubMed ID: 29951051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants.
    Jackman RP; Deng X; Bolgiano D; Lebedeva M; Heitman JW; Busch MP; Slichter SJ; Norris PJ
    Blood; 2013 Apr; 121(16):3261-6; quiz 3299. PubMed ID: 23393051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.